ClinConnect ClinConnect Logo
Search / Trial NCT06707116

Health Literacy As a Mediator Between Gender, Illness Identity, and Self-Efficacy

Launched by CAIRO UNIVERSITY · Nov 24, 2024

Trial Information

Current as of July 28, 2025

Not yet recruiting

Keywords

Health Literacy Gender Differences

ClinConnect Summary

This clinical trial is studying how health literacy, which is the ability to understand and use health information, affects elderly patients with heart diseases. Researchers want to find out if a person's understanding of health information influences the connection between their gender, how they view their illness, and their confidence in managing their health (this is called self-efficacy). The study will involve participants completing online surveys over a year to share their experiences and feelings about their health.

To participate in this study, you need to be at least 30 years old and have a diagnosed heart condition, such as heart failure or arrhythmia. You should also be able to understand the survey questions and be receiving regular medical care for your heart issue. Unfortunately, individuals with severe cognitive impairments or terminal illnesses will not be eligible to participate. If you join the study, you'll help researchers learn more about how health literacy can impact the lives of elderly patients with heart diseases, potentially leading to improved care and support in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 30 years or older.
  • Diagnosed with a cardiac disease (e.g., heart failure, coronary artery disease, arrhythmia).
  • Able to provide informed consent.
  • Sufficient health literacy to complete surveys in the study language.
  • Currently under regular medical care for their cardiac condition.
  • Exclusion Criteria:
  • Individuals with a cognitive impairment or diagnosis of dementia that could interfere with survey participation.
  • Patients with co-morbid terminal illnesses that significantly impact life expectancy (e.g., advanced cancer).

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported